Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment

Advances in cancer immunity have promoted a major breakthrough in the field of cancer therapy. This is mainly associated with the successful development of immune checkpoint inhibitors (ICIs) for multiple types of human tumors. Blockade with different ICIs, including programmed cell death 1 (PD-1),...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Yuxiao, Fu, Yang, Xie, Qi, Zhu, Bo, Wang, Jun, Zhang, Bicheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477085/
https://www.ncbi.nlm.nih.gov/pubmed/32983126
http://dx.doi.org/10.3389/fimmu.2020.01956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477085/
https://www.ncbi.nlm.nih.gov/pubmed/32983126
http://dx.doi.org/10.3389/fimmu.2020.01956

Ejemplares similares